Microchip Technology Inc. (MCHP)

Microchip Technology's shares fell 10.02% in the first session after its November 5, 2026 earnings report, even though adjusted EPS of $0.97 beat the estimate by 3.19%. The stock closed at $60.33, down 1.90% on the last session, and sits 43.04% below its 52-week high of $105.91. The selloff has left the stock below its 50-day and 200-day moving averages ($74.36 and $79.46), with the trend and momentum readings firmly negative. For investors, the key question is whether a company with 42.20% year-on-year revenue growth can regain the ground lost after the report, while the stock trades at a premium to sector peers on earnings.

Microchip beat the EPS estimate on November 5, 2026, reporting $0.97 on an adjusted basis, 3.19% above forecast. The stock still fell 10.02% in the first trading session after the report. This is the most unusual feature of the recent record: of the eight recent reports, seven beat the estimate, yet five of those beats were followed by a lower share price in the first session. The market appears to be looking past headline beats toward guidance, margins and the valuation the company commands.

The trailing P/E ratio of 45.36, 29.2% above the sector median of 35.1, which marks it as a premium to peers.

The net profit margin is 13.0% and the operating margin is 29.13%. Return on equity of 12.57% is below the sector median of 13.4%, and the debt-to-equity ratio is 0.84.

Insiders sold $72.4M of stock over the last 18 months across 23 sales, and made no open-market purchases. Insider sales are often planned in advance or made to cover tax on vesting shares, so they are a weaker signal than open-market buying, but the absence of insider purchases after a steep fall offers no offsetting signal.

The base case is that MCHP stays under pressure until the price reclaims its moving averages. The stock is below the 20-day EMA at $71.56, the 50-day SMA at $74.36 and the 200-day SMA at $79.46, so a sustained move back above those levels would be the first sign the trend is turning. Analysts remain constructive: 21 of 26 rate the stock Buy or Strong Buy, none rate it Sell, and the median 12-month target is $85.00, with a range from $62.00 to $120.00. The bullish case rests on those targets proving right as revenue growth continues. The bearish case is that the post-earnings reaction signals investors doubt the earnings quality or the premium valuation, and the price tests the 52-week low at $48.52. Because the stock has a beta of 1.85 and a typical daily move of 4.11%, sharp swings in either direction are normal for this share.

Support sits at the 52-week low of $48.52, the lowest price in the past year and the level a further fall would meet first. Resistance sits at the 20-day EMA of $71.56, the nearest level above the price, followed by the 50-day SMA at $74.36 and the 200-day SMA at $79.46. The 52-week high of $105.91 is the far resistance level. A rise through $71.56 and $74.36 would be needed to suggest the short-term trend is improving.